These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21355744)

  • 21. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.
    Gardner SY; Davis JL; Jones SL; LaFevers DH; Hoskins MS; McArver EM; Papich MG
    J Vet Pharmacol Ther; 2004 Feb; 27(1):57-60. PubMed ID: 14995968
    [No Abstract]   [Full Text] [Related]  

  • 22. Penetration of moxifloxacin into the human aqueous humour after oral administration.
    Kampougeris G; Antoniadou A; Kavouklis E; Chryssouli Z; Giamarellou H
    Br J Ophthalmol; 2005 May; 89(5):628-31. PubMed ID: 15834098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.
    Amar T; Caillaud T; Elena PP
    Curr Eye Res; 2008 Feb; 33(2):149-58. PubMed ID: 18293185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.
    De Smet J; Boussery K; Colpaert K; De Sutter P; De Paepe P; Decruyenaere J; Van Bocxlaer J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):961-7. PubMed ID: 19272845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
    Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
    Behrens-Baumann W
    Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration.
    Sun XG; Wang ZX; Wang ZQ; Deng SJ; Li R; Luo SY; Wu YY
    Ophthalmic Res; 2007; 39(2):81-3. PubMed ID: 17284933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of intravitreal moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phakic status affects vitreous penetration of topical moxifloxacin.
    Fuller JJ; McGwin G
    Arch Ophthalmol; 2006 May; 124(5):749; author reply 749. PubMed ID: 16682605
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic evaluation and safety of topical 1% morphine sulfate application on the healthy equine eye.
    Gordon E; Stang BV; Heidel J; Poulsen KP; Cebra CK; Schlipf JW
    Vet Ophthalmol; 2018 Sep; 21(5):516-523. PubMed ID: 29350477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of topical 0.3% ciprofloxacin into human aqueous humor.
    Kalayci D; Basci N; Akpek E; Hasiripi H; Bozkurt A
    Ophthalmic Surg Lasers; 1996 Jan; 27(1):21-4. PubMed ID: 8630751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tear concentrations of topically applied ciprofloxacin.
    Limberg M; Buggé C
    Cornea; 1994 Nov; 13(6):496-9. PubMed ID: 7842707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous humor and plasma concentrations of a compounded 0.2% solution of terbinafine following topical ocular administration to normal equine eyes.
    Clode A; Davis J; Davidson G; Salmon J; Lafevers H; Gilger B
    Vet Ophthalmol; 2011 Jan; 14(1):41-7. PubMed ID: 21199278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxycycline levels in preocular tear film of horses following oral administration.
    Baker A; Plummer CE; Szabo NJ; Barrie KP; Brooks DE
    Vet Ophthalmol; 2008; 11(6):381-5. PubMed ID: 19046279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP; Sawusch MR; Dick JD; Gottsch JD
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.